Mats Ohlin
201 – 210 of 229
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 1994
-
Mark
Flow cytometric analysis of the stability of antibody production by human × human × mouse heterohybridoma subclones
(
- Contribution to journal › Article
- 1993
-
Mark
Pharmacokinetic and pharmacologic properties of antiuterotonic oxytocin analogs in the rat
(
- Contribution to journal › Article
-
Mark
Fine specificity and neutralizing activity of human serum antibodies directed to the major antigenic region on gp 116 of human cytomegalovirus
(
- Contribution to journal › Article
-
Mark
Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies
(
- Contribution to journal › Article
-
Mark
Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines
(
- Contribution to journal › Article
-
Mark
Does endogenous glycosylation prevent the use of mouse monoclonal antibodies as cancer therapeutics?
(
- Contribution to journal › Article
- 1992
-
Mark
Human peripheral blood lymphocytes transplanted into SCID mice constitute an in vivo culture system exhibiting several parameters found in a normal humoral immune response and are a source of immunocytes for the production of human monoclonal antibodies.
(
- Contribution to journal › Article
-
Mark
Real time analysis of antibody-antigen reaction kinetics.
(
- Contribution to journal › Article
-
Mark
Evaluation of the degradation of desamino1,D-arginine8-vasopressin by nasal mucosa.
(
- Contribution to journal › Article
-
Mark
Human monoclonal antibody technology. A tool to investigate human antibody repertoires.
1992)(
- Thesis › Doctoral thesis (compilation)